Ping An Biomedical Co., Ltd.
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsPing An Biomedical Co., Ltd. is a Hong Kong-based shell company with nominal revenue and an apparel industry classification, listed on Nasdaq.
What they do
Ping An Biomedical Co., Ltd. is a Cayman Islands holding company with principal executive offices in Hong Kong. The filing provides no operational details; the company is classified under the apparel and finished fabrics industry but reports no product or service descriptions. It is listed on the Nasdaq Capital Market under the ticker PASW.
Recent performance
For fiscal year 2025, the company reported annual revenue of $4.8 million and a net loss of $1.8 million, with diluted EPS of -$0.10. Operating cash flow was negative at -$902,902. As of September 30, 2025, total assets were $9.6 million, total liabilities $3.3 million, and shareholder equity $6.4 million, with cash and equivalents of $164,697.
Strategy
The filing does not disclose any specific business strategy, product development efforts, or investment priorities. The company identifies itself as an emerging growth company and notes risks related to limited operating history and the timing of future business development. No operational initiatives or market plans are described.
Risks
- Limited operating history — The company has a limited operating history, which increases uncertainty about its ability to execute a business plan.
- Negative cash flow — Operating cash flow was -$902,902 in FY2025, indicating ongoing cash consumption.
- Low cash reserves — Cash and equivalents were only $164,697 as of September 30, 2025, which may be insufficient to fund operations for an extended period.
- No disclosed operations — The filing provides no information on actual products, customers, or business segments, creating significant uncertainty about the company's viability.
Outlook
The filing does not provide specific forward-looking guidance on revenue, profitability, or operational milestones. Management cites general risks including government, economic, and political circumstances, as well as market acceptance of services and products. The outlook is highly uncertain given the lack of disclosed operational details and the small scale of reported financials.